These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 11919655)
1. Is Na(+) required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter? Li LB; Cui XN; Reith MA Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):303-11. PubMed ID: 11919655 [TBL] [Abstract][Full Text] [Related]
2. Interaction of Na+, K+, and Cl- with the binding of amphetamine, octopamine, and tyramine to the human dopamine transporter. Li LB; Reith ME J Neurochem; 2000 Apr; 74(4):1538-52. PubMed ID: 10737611 [TBL] [Abstract][Full Text] [Related]
3. Interaction between dopamine and its transporter: role of intracellular sodium ions and membrane potential. Chen N; Reith ME J Neurochem; 2004 May; 89(3):750-65. PubMed ID: 15086531 [TBL] [Abstract][Full Text] [Related]
4. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine. Chen N; Zhen J; Reith ME J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185 [TBL] [Abstract][Full Text] [Related]
5. Modeling of the pH dependence of the binding of WIN 35,428 to the dopamine transporter in rat striatal membranes: is the bioactive form positively charged or neutral? Xu C; Reith ME J Pharmacol Exp Ther; 1996 Sep; 278(3):1340-8. PubMed ID: 8819521 [TBL] [Abstract][Full Text] [Related]
6. Modeling of the interaction of Na+ and K+ with the binding of dopamine and [3H]WIN 35,428 to the human dopamine transporter. Li LB; Reith ME J Neurochem; 1999 Mar; 72(3):1095-109. PubMed ID: 10037481 [TBL] [Abstract][Full Text] [Related]
7. Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells. Chen N; Reith ME J Neurochem; 2007 Apr; 101(2):377-88. PubMed ID: 17250655 [TBL] [Abstract][Full Text] [Related]
8. Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake. Chen N; Trowbridge CG; Justice JB J Pharmacol Exp Ther; 1999 Sep; 290(3):940-9. PubMed ID: 10454463 [TBL] [Abstract][Full Text] [Related]
9. WIN 35,428 and mazindol are mutually exclusive in binding to the cloned human dopamine transporter. Xu C; Reith ME J Pharmacol Exp Ther; 1997 Aug; 282(2):920-7. PubMed ID: 9262359 [TBL] [Abstract][Full Text] [Related]
10. Binding of cocaine-like radioligands to the dopamine transporter at 37 degrees C: effect of Na+ and substrates. Wang LC; Cui XN; Chen N; Reith ME J Neurosci Methods; 2003 Dec; 131(1-2):27-33. PubMed ID: 14659820 [TBL] [Abstract][Full Text] [Related]
11. Differences in interactions with the dopamine transporter as revealed by diminishment of Na(+) gradient and membrane potential: dopamine versus other substrates. Zhen J; Chen N; Reith ME Neuropharmacology; 2005 Nov; 49(6):769-79. PubMed ID: 16122767 [TBL] [Abstract][Full Text] [Related]
12. [3H]WIN 35,428 binding in the caudate nucleus of the rabbit: evidence for a single site on the dopamine transporter. Aloyo VJ; Ruffin JS; Pazdalski PS; Kirifides AL; Harvey JA J Pharmacol Exp Ther; 1995 Apr; 273(1):435-44. PubMed ID: 7714799 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046 [TBL] [Abstract][Full Text] [Related]
14. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. Staley JK; Hearn WL; Ruttenber AJ; Wetli CV; Mash DC J Pharmacol Exp Ther; 1994 Dec; 271(3):1678-85. PubMed ID: 7996484 [TBL] [Abstract][Full Text] [Related]
15. Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopamine transporter. Lee SH; Chang MY; Lee KH; Park BS; Lee YS; Chin HR; Lee YS Mol Pharmacol; 2000 May; 57(5):883-9. PubMed ID: 10779370 [TBL] [Abstract][Full Text] [Related]
16. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter. Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648 [TBL] [Abstract][Full Text] [Related]
17. Cationic interactions at the human dopamine transporter reveal binding conformations for dopamine distinguishable from those for the cocaine analog 2 alpha-carbomethoxy-3 alpha-(4-fluorophenyl)tropane. Chen N; Sun L; Reith ME J Neurochem; 2002 Jun; 81(6):1383-93. PubMed ID: 12068085 [TBL] [Abstract][Full Text] [Related]
18. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue. Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005 [TBL] [Abstract][Full Text] [Related]
19. Relationships between the catechol substrate binding site and amphetamine, cocaine, and mazindol binding sites in a kinetic model of the striatal transporter of dopamine in vitro. Wayment H; Meiergerd SM; Schenk JO J Neurochem; 1998 May; 70(5):1941-9. PubMed ID: 9572278 [TBL] [Abstract][Full Text] [Related]
20. Na+ stimulates binding of dopamine to the dopamine transporter in cells but not in cell-free preparations. Chen N; Rickey J; Reith ME J Neurochem; 2003 Aug; 86(3):678-86. PubMed ID: 12859681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]